Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.
- Resource Type
- Article
- Source
Science Advances . 10/8/2021, Vol. 7 Issue 41, p1-13. 13p.- Subject
- *
IRINOTECAN
*CANCER invasiveness
*COLON cancer
*CREATINE
*CELL death
*CANCER cells
*THERAPEUTICS - Language
- ISSN
- 2375-2548